However, the use of recent COVID-19 vaccines containing antigens derived from Omicron-like strains, which are genetically more similar to BA.2.86 and JN.1 than the ancestral strain, may reduce the impact of BA.2.86 and JN.1 mutations on vaccine-induced responses even further. The gene discussed is ERMN; the disease is COVID-19.